MAR vs MRNA · P/E 32, rev $13.72B vs rev $145.0M
Marriott International Inc (MAR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported MAR revenue for 2026-06-30 was $13.72B. Net income was $1.41B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the MAR and MRNA stock pages for the full models.
Not investment advice.